Patient number | sPLA2staining score | Histological inflammation score | |||||||
---|---|---|---|---|---|---|---|---|---|
EC | VSM | SLL | LL | Cumulative | LLT | MC | Cumulative | ||
Rheumatoid arthritis | |||||||||
1 | 3 | 3 | 2.1 | 2.8 | 10.9 | 1 | 1 | 2 | |
2 | 2.1 | 2.1 | 1.6 | 2.7 | 8.5 | 2 | 0.6 | 2.6 | |
3 | 0.8 | 0.8 | 1 | 1.1 | 3.7 | 1 | 1 | 2 | |
4 | 2.9 | 2.9 | 2.7 | 2.8 | 11.3 | 2 | 1 | 3 | |
5 | 0.1 | 0.1 | 0.3 | 1.2 | 1.7 | 1 | 0.9 | 1.9 | |
6 | 0.3 | 0.3 | 1 | 1.8 | 3.4 | 1 | 1.2 | 2.2 | |
7 | 3 | 3 | 3 | 3 | 12 | 1 | 1.2 | 2.2 | |
8 | 1.5 | 1.5 | 1.3 | 1.6 | 5.9 | 0 | 1.1 | 1.1 | |
9 | 3 | 3 | 3 | 3 | 12 | 2 | 0.9 | 2.9 | |
10 | 2.7 | 1.8 | 2.3 | 0 | 6.8 | 0 | 0 | 0 | |
Osteoarthritis | |||||||||
11 | 0.6 | 0.6 | 0 | 0 | 1.2 | 0 | 0.3 | 0.3 | |
12 | 0.6 | 0.6 | 0 | 0 | 1.2 | 0 | 0.6 | 0.9 | |
13 | 2 | 1.9 | 2.1 | 0.5 | 6.5 | 0 | 0 | 0 | |
14 | 3 | 3 | 2.7 | 2.6 | 11.3 | 0 | 0 | 0 | |
15 | 1.6 | 0.8 | 0.9 | 1.5 | 4.8 | 1 | 0 | 1 | |
16 | 2.4 | 2.5 | 2 | 0 | 6.9 | 0 | 0.2 | 0.2 | |
17 | 2.9 | 2.6 | 2.6 | 2.3 | 10.4 | 0 | 0.1 | 0.1 | |
18 | 1.7 | 1.6 | 1.6 | 0.3 | 5.2 | 0 | 0.4 | 0.4 | |
19 | 1.4 | 1.4 | 0.5 | 0 | 3.3 | 0 | 0.4 | 0.4 | |
20 | 0.4 | 0.6 | 0.4 | 0 | 1.4 | 0 | 0 | 0 | |
Non-arthritic | |||||||||
21 | 0.3 | 0.3 | 0 | 0 | 0.6 | 0 | 0.1 | 0.1 | |
22 | 0 | 0.5 | 0.6 | 0 | 1.1 | 0 | 0 | 0 | |
23 | 0.2 | 0.2 | 0 | 0 | 0.4 | 0 | 0 | 0 | |
24 | 1 | 1.2 | 0 | 0 | 2.2 | 0 | 0 | 0 | |
25 | 2 | 1.0 | 1.7 | 0 | 4.7 | 1 | 0.3 | 1.3 | |
26 | 2.5 | 2.4 | 0 | 0 | 4.9 | 0 | 0 | 0 | |
27 | 0.4 | 0.2 | 0 | 0 | 0.6 | 0 | 0 | 0 | |
28 | 0.9 | 0.1 | 0.6 | 0 | 1.6 | 0 | 0 | 0 | |
29 | 1.3 | 1.0 | 0 | 0 | 2.3 | 0 | 0 | 0 | |
30 | 2.9 | 2.9 | 2.9 | 3 | 11.7 | 0 | 0.1 | 0.1 |
EC, endothelium; VSM, vascular smooth muscle; SLL subsynovial lining layer; LL, synovial lining layer; LLT, synovial lining thickness; MC, mononuclear cell infiltrates. Scoring was performed as described in methods.